---
title: Pano2 Syngeneic Model - TD2 Precision Oncology
description: Explore Pano2, a valuable pancreatic adenocarcinoma cell line for studying tumor progression and therapeutic interventions in pancreatic cancer research.
image: https://td2inc.com/hubfs/Assets/GraphsFigures/pano2.png
---
×
[](https://td2inc.com/?hsLang=en)
[](https://td2inc.com/?hsLang=en)
# Pano2 Syngeneic Model
**Synonyms:** Pano2 cells, Pano2 pancreatic cancer cell line, Pano2 pancreatic adenocarcinoma cells.
Pano2 is a widely studied cancer cell line derived from pancreatic adenocarcinoma. Known for its aggressive behavior and relevance to pancreatic cancer research, Pano2 cells offer valuable insights into tumor progression, metastasis, and therapeutic interventions. Researchers utilize Pano2 to investigate the molecular mechanisms underlying pancreatic cancer and evaluate potential treatments. Its well-characterized features make it a valuable tool for understanding pancreatic cancer biology and advancing therapeutic strategies.
## Model Details
**Cancer Type:** Pancratic Cancer
**Model Name:** Pano2
**Mouse Strain:** C57BL/6
**Treatment Data Available:** aPD-1, aTIM-3
## Pano2 Growth Curves: Response to aPD-1 and aTIM-3
Growth of subcutaneous Pan02 in C57BL/6 mice (n=10). Response to a PD-1 dosed Q3Dx4 and aTIM-3.
### Request Additional Syngeneic Model Data
## CONTACT US
## Get Started.
Have questions about how TD2 can assist with your regulatory needs? Reach out to our expert staff today to get started.
[Get Started Now](https://td2inc.com/contact-us/?hsLang=en)
[](https://td2inc.com/?hsLang=en)
Office
13208 E. Shea Blvd,
Suite 100
Scottsdale, AZ 85259
Phone
(602) 358-8300
Connect with us
-
-
© 2026 Translational Drug Development. All Rights Reserved. [Terms and Conditions](https://td2inc.com/terms-and-conditions?hsLang=en) | [Privacy Policy](https://td2inc.com/privacy-policy?hsLang=en)